| 3CLpro | 3C-like protease |
| ACE2 | angiotensin-converting enzyme 2 |
| ADAM17 | ADAM metallopeptidase domain 17 |
| Ang | angiotensin |
| ARDS | acute respiratory distress syndrome |
| cGMP | cyclic guanosine monophosphate |
| COVID-19 | coronavirus disease 2019 |
| CRS | cytokine-release syndrome |
| DIC | disseminated intravascular coagulation |
| E | envelope |
| ECs | endothelial cells |
| ED | endothelial dysfunction |
| HIF-1α | hypoxia-inducible factor 1α |
| ICAM-1 | intracellular adhesion molecule 1 |
| ICU | intensive care unit |
| INFγ IV |
Interferon-γ intravenous |
| LMWH | low-molecular-weight heparin |
| M | membrane-associated |
| MMP-2 | matrix metalloproteinase 2 |
| Mpro | major protease inhibitor |
| N | nucleocapsid |
| NETosis | neutrophil extracellular traps |
| NF-κB | nuclear factor κB |
| NO | nitric oxide |
| PAI-1 | plasminogen activator inhibitor 1 |
| PDGF | platelet-derived growth factor |
| PFT | pulmonary function test |
| POTS | postural tachycardia syndrome |
| RAAS | renin–angiotensin–aldosterone system |
| RBD | receptor-binding domain |
| ROS | reactive oxygen species |
| S | spike |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| SDC1 | syndecan-1 |
| SpO2 | peripheral oxygen saturation |
| sVCAM1 | soluble vascular cell adhesion molecule 1 |
| TF | tissue factor |
| TLRs | Toll-like receptors |
| TMPRSS-2 | transmembrane protease serine protease-2 |
| TNF | tumor necrosis factor |
| uPA | urokinase plasminogen activator |
| URTI | upper respiratory tract infection |
| VEGF | vascular endothelial growth factor |
| VWF | von Willebrand factor |
| WHO | World Health Organization |